Treatment of Left Ventricular Apical Thrombus

Initial Diagnostic Confirmation

The European Society of Cardiology recommends performing transthoracic echocardiography immediately to confirm the presence, size, mobility, and characteristics of the apical thrombus, with cardiac MRI or transesophageal echocardiography as alternatives for better visualization if echocardiographic windows are inadequate 1
Assess for high-risk features including mobile thrombus, poor adherence, or location in high-flow areas that increase embolic risk, as suggested by the American Heart Association 1

The American College of Cardiology recommends starting warfarin immediately with target INR 2.0-3.0 in combination with low-dose aspirin for patients with left ventricular apical thrombus, with a strength of evidence rated as high 2, 3
Bridge with low molecular weight heparin or unfractionated heparin until INR is therapeutic, as recommended by the European Heart Journal 4, 3
Continue anticoagulation for up to 6 months, with duration guided by repeated imaging, according to the European Society of Cardiology 5

Perform serial echocardiography to assess thrombus resolution—typically at 2 weeks, 1 month, 3 months, and 6 months, as recommended by the American Heart Association 5, 6, 7
Monitor INR at least weekly during warfarin initiation and monthly once stable, maintaining time in therapeutic range >70%, as suggested by the European Society of Cardiology 7

Continue anticoagulation beyond 6 months if persistent apical akinesia remains even after thrombus resolution and LVEF improvement, as recommended by the European Heart Journal 5, 6
For patients with ejection fraction <25% or shortening fraction ≤10%, consider ongoing anticoagulation even after thrombus resolution, according to the American College of Cardiology 1

For thrombus causing hemodynamic obstruction, valve dysfunction, or highly mobile/poorly adherent thrombus at high embolic risk: consider thrombolytic therapy or surgical thrombectomy, as recommended by the American Heart Association 1
If systemic embolization occurs (stroke), perform immediate neuroimaging to exclude hemorrhage before any intervention, as suggested by the European Society of Cardiology 6

Never delay anticoagulation once LV thrombus is confirmed—this significantly increases embolic stroke risk, as warned by the American College of Cardiology 6, 7
Do not stop anticoagulation early based solely on symptom improvement or LVEF recovery without imaging confirmation of thrombus resolution, as recommended by the European Heart Journal 5, 6

The European Society of Cardiology recommends starting NOACs immediately upon diagnosis and continuing for a minimum of 3-6 months, with duration guided by repeated imaging 8, 9

The European Society of Cardiology suggests continuing anticoagulation indefinitely if persistent apical akinesia remains, even after documented thrombus resolution and LVEF improvement 8, 9
The European Society of Cardiology advises against discontinuing anticoagulation based solely on thrombus resolution if high-risk features persist, such as persistent wall motion abnormalities 8, 9